Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-07Clinical Trial Update: A Chinese Patent Medicine Yangzhengxiaoji Capsule to Improve the Nausea of Niraparib in the Maintenance Treatment in Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating Yangzhengxiaoji Capsule added to niraparib maintenance therapy to improve nausea in ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer [Phase 2]
A Phase 2 clinical trial update evaluating Fluzopari in combination with Apatinib for neoadjuvant treatment of unresectable ovarian cancer. …
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating gemcitabine hydrochloride alone or in combination with M6620 for recurrent ovarian, fallopian tube, or pri…
-
CLINICAL_TRIALS trial_result · 2022-10-05Clinical Trial Update: Olaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer With BRCA1 or BRCA2 Mutation [Phase 2]
Phase 2 trial evaluating the combination of olaparib, durvalumab, and tremelimumab in patients with BRCA1/BRCA2-mutated recurrent or refract…
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients [Phase 3]
Phase 3 clinical trial evaluating maintenance olaparib with cediranib vs olaparib alone in ovarian cancer; status not specified.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab [NA]
Clinical trial assessing perfusion CT to predict outcomes in ovarian, fallopian tube, or peritoneal cancer treated with bevacizumab; the stu…
-
CLINICAL_TRIALS trial_result · 2022-09-26Clinical Trial Update: Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy [Phase 4]
Phase 4 trial assessing aspirin for prevention of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy has c…
-
CLINICAL_TRIALS trial_result · 2022-09-23Clinical Trial Update: Olaparib After Response to Trabectedin-pegylated Liposomal Doxorubicin in Recurrent Ovarian Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating olaparib after response to trabectedin-pegylated liposomal doxorubicin in recurrent ovarian carcino…
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating a vaccine therapy with paclitaxel and carboplatin in patients undergoing surgery for advanced ovarian cancer, prima…
-
CLINICAL_TRIALS trial_result · 2022-09-10Clinical Trial Update: A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer [Phase 2]
Phase II single-arm pilot study of the Chk1/2 inhibitor LY2606368 in BRCA1/2 mutation-associated breast or ovarian cancer, triple negative b…
-
CLINICAL_TRIALS trial_result · 2022-09-10Clinical Trial Update: Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy [Phase 2]
Phase 2 trial evaluating regorafenib in metastatic solid tumors that progressed after standard therapy has completed, with multiple indicate…
-
CLINICAL_TRIALS trial_result · 2022-09-01Clinical Trial Update: Effect of Hemp-CBD on Patients With CIPN [Phase 2]
Phase 2 clinical trial investigating the effect of hemp-derived CBD on chemotherapy-induced peripheral neuropathy.
-
CLINICAL_TRIALS trial_result · 2022-08-30Clinical Trial Update: Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 trial comparing niraparib alone to niraparib with bevacizumab in platinum-sensitive epithelial ovarian cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2022-08-29Clinical Trial Update: A Study of Niraparib in Patients With Relapsed Ovarian Cancer [Phase 2]
Phase 2 trial evaluating niraparib in relapsed ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-29Clinical Trial Update: A Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation [Phase 2]
Phase 2 trial of BBI503 in asymptomatic recurrent ovarian cancer with CA-125 elevation was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-08-15Clinical Trial Update: A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer [Phase 3]
A Phase 3 clinical trial update for navicixizumab in platinum-resistant ovarian cancer is underway, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-08-02Clinical Trial Update: Platine, Avastin and OLAparib in 1st Line [Phase 3]
Phase 3 trial update involving Platine, Avastin, and OLAparib in first-line ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-07-27Clinical Trial Update: Adjuvant Chemotherapy of Three-step Regimen in Ovarian Cancer [Phase 2]
Phase 2 clinical trial update evaluating a three-step adjuvant chemotherapy regimen in ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2022-07-27Clinical Trial Update: Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2) [Phase 3]
A Phase 3 clinical trial update on an adjuvant three-step chemotherapy regimen for BRCA1/2 wild-type ovarian cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Pembrolizumab and Carboplatin in Treating Patients With Relapsed or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating pembrolizumab in combination with carboplatin for relapsed or refractory ovarian, fallopian tube, or p…
-
CLINICAL_TRIALS trial_result · 2022-07-20Clinical Trial Update: Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancer [Phase 3]
Phase 3 clinical trial evaluating the optimal duration of bevacizumab in combination with standard chemotherapy for ovarian cancer has compl…
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial update of intraperitoneal aerosol high-pressure chemotherapy for recurrent ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer [Phase 2]
Phase 2 study of OTL38 for intra-operative imaging in folate receptor-alpha positive ovarian cancer has completed with posted results in 202…
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a vaccine therapy in combination with trastuzumab for patients with Stage IV HER2-positive breast cancer or ova…
-
CLINICAL_TRIALS trial_result · 2022-06-16Clinical Trial Update: Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial exploring Envafolimab and Lenvatinib combined with VP-16 for platinum-resistant recurrent epithelial ovarian cancer is underwa…